These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 4112608)

  • 1. Adrenergic blockade in hypertension.
    Lancet; 1972 May; 1(7760):1125-6. PubMed ID: 4112608
    [No Abstract]   [Full Text] [Related]  

  • 2. Adrenergic blockade in hypertension.
    Lewis PJ; George CF; Dollery CT
    Lancet; 1972 Jun; 1(7762):12232-3. PubMed ID: 4113201
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of essential hypertension with a new vasodilator in combination with beta-adrenergic blockade.
    Gilmore E; Weil J; Chidsey C
    N Engl J Med; 1970 Mar; 282(10):521-7. PubMed ID: 4391708
    [No Abstract]   [Full Text] [Related]  

  • 4. Mechanism of beta-blockade hypotension.
    Frohlich ED
    N Engl J Med; 1972 Dec; 287(24):1247-8. PubMed ID: 4404400
    [No Abstract]   [Full Text] [Related]  

  • 5. Experiences with beta-adrenergic blockade drugs in hypertension.
    Seedat YK; Stewart-Wynne EG; Reddy J; Randeree M
    S Afr Med J; 1973 Feb; 47(7):259-62. PubMed ID: 4143987
    [No Abstract]   [Full Text] [Related]  

  • 6. The treatment of hypertension by beta adrenergic blocking drugs.
    Prichard BN
    Angiologica; 1966; 3(5):318-29. PubMed ID: 4381049
    [No Abstract]   [Full Text] [Related]  

  • 7. Double blind controlled trial of indoramin in the treatment of essential hypertension.
    Dollery DT; George DG; Lewis PJ
    Br J Pharmacol; 1972 Nov; 46(3):542P-543P. PubMed ID: 4571183
    [No Abstract]   [Full Text] [Related]  

  • 8. Vasodilation in treatment of hypertension.
    Chidsey CA
    N Engl J Med; 1970 May; 282(19):1102-3. PubMed ID: 4392414
    [No Abstract]   [Full Text] [Related]  

  • 9. An approach to the treatment of essential hypertension.
    Vlachakis ND; Mendlowitz M
    Am Heart J; 1976 Dec; 92(6):750-7. PubMed ID: 998482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Coronary and left ventricular dynamics of three substances with different beta-blocking effects: Propranolol, Pindolol, and Practolol].
    Moccetti T; Halter J; Lichtlen P
    Schweiz Med Wochenschr; 1972 Mar; 102(12):422-5. PubMed ID: 4401753
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of prolonged treatment with adrenergic beta-receptor antagonists on blood pressure, cardiovascular design and reactivity in spontaneously hypertensive rats (SHR).
    Weiss L; Lundgren Y; Folkow B
    Acta Physiol Scand; 1974 Aug; 91(4):447-57. PubMed ID: 4154700
    [No Abstract]   [Full Text] [Related]  

  • 12. [Medical support in surgery for pheochromocytoma].
    Schmucki O
    Helv Chir Acta; 1979 Aug; 46(3):287-90. PubMed ID: 489398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Combination of beta blockaders with vasodilator substances in hypertension].
    Stenbaek O
    Tidsskr Nor Laegeforen; 1974 Jan; 94(3):177-8. PubMed ID: 4150720
    [No Abstract]   [Full Text] [Related]  

  • 14. Combined alpha and beta sympathetic blockade in hyperthyroidism. Clinical and metabolic effects.
    Stout BD; Wiener L; Cox JW
    Ann Intern Med; 1969 May; 70(5):963-70. PubMed ID: 5769628
    [No Abstract]   [Full Text] [Related]  

  • 15. [Changes induced by acute and prolonged administration of propranolol in systemic hemodynamics in hypertensive patients].
    Branzi A; Sanguinetti M; Ambrosioni E; Magnani B
    Boll Soc Ital Cardiol; 1970; 15(6):627-33. PubMed ID: 5517658
    [No Abstract]   [Full Text] [Related]  

  • 16. The short-term effects of adrenergic-blocking agents in a small group of psychotic patients. Preliminary clinical observations.
    Atsmon A; Blum I; Wijsenbeek H; Maoz B; Steiner M; Ziegelman G
    Psychiatr Neurol Neurochir; 1970; 74(3):251-8. PubMed ID: 4397229
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of anapriline on myocardial contraction and systemic vascular resistance in patients with stage II hypertension].
    Tokarenko II
    Klin Med (Mosk); 1990 Dec; 68(12):15-7. PubMed ID: 1982154
    [No Abstract]   [Full Text] [Related]  

  • 18. [Mechanism of the antihypertensive action of propranolol].
    Magnani B; Ambrosioni E; Branzi A; Maresta A; Picchio F; Russo F; Sanguinetti M
    Minerva Cardioangiol; 1973 Apr; 21(4):284-97. PubMed ID: 4710125
    [No Abstract]   [Full Text] [Related]  

  • 19. Cardiovascular response in hyperthyroidism. The influence of adrenergic-receptor blockade.
    Pietras RJ; Real MA; Poticha GS; Bronsky D; Waldstein SS
    Arch Intern Med; 1972 Mar; 129(3):426-9. PubMed ID: 4401571
    [No Abstract]   [Full Text] [Related]  

  • 20. The use of propranolol in hypertension: a review.
    Hansson L
    Postgrad Med J; 1976; 52 Suppl 4():77-80. PubMed ID: 9634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.